148 related articles for article (PubMed ID: 19539650)
1. Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes.
Kranidioti H; Orfanos SE; Vaki I; Kotanidou A; Raftogiannis M; Dimopoulou I; Kotsaki A; Savva A; Papapetropoulos A; Armaganidis A; Giamarellos-Bourboulis EJ
Immunol Lett; 2009 Jun; 125(1):65-71. PubMed ID: 19539650
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the release of Ang-2 in experimental endotoxic shock by a species-specific circulating factor.
Carrer DP; Kotzampassi K; Fyntanidou B; Grosomanidis V; Papapetropoulos A; Lymperi M; Giamarellos-Bourboulis EJ
Injury; 2013 Jul; 44(7):935-40. PubMed ID: 23642845
[TBL] [Abstract][Full Text] [Related]
3. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis.
Kümpers P; van Meurs M; David S; Molema G; Bijzet J; Lukasz A; Biertz F; Haller H; Zijlstra JG
Crit Care; 2009; 13(3):R64. PubMed ID: 19416526
[TBL] [Abstract][Full Text] [Related]
4. CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.
de Werra I; Zanetti G; Jaccard C; Chioléro R; Schaller MD; Yersin B; Glauser MP; Calandra T; Heumann D
Swiss Med Wkly; 2001 Jan; 131(3-4):35-40. PubMed ID: 11219189
[TBL] [Abstract][Full Text] [Related]
5. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.
Zweigner J; Gramm HJ; Singer OC; Wegscheider K; Schumann RR
Blood; 2001 Dec; 98(13):3800-8. PubMed ID: 11739189
[TBL] [Abstract][Full Text] [Related]
6. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.
Luz Fiusa MM; Costa-Lima C; de Souza GR; Vigorito AC; Penteado Aranha FJ; Lorand-Metze I; Annichino-Bizzacchi JM; de Souza CA; De Paula EV
Crit Care; 2013 Aug; 17(4):R169. PubMed ID: 23915833
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 associations with the underlying infection and sepsis severity.
Lymperopoulou K; Velissaris D; Kotsaki A; Antypa E; Georgiadou S; Tsaganos T; Koulenti D; Paggalou E; Damoraki G; Karagiannidis N; Orfanos SE
Cytokine; 2015 May; 73(1):163-8. PubMed ID: 25748839
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.
Sfeir T; Saha DC; Astiz M; Rackow EC
Crit Care Med; 2001 Jan; 29(1):129-33. PubMed ID: 11176172
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Circulating IL-10-Producing Cells in Septic Shock Patients: A Proof of Concept Study.
Fabri A; Kandara K; Coudereau R; Gossez M; Abraham P; Monard C; Cour M; Rimmelé T; Argaud L; Monneret G; Venet F
Front Immunol; 2020; 11():615009. PubMed ID: 33613540
[TBL] [Abstract][Full Text] [Related]
11. Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?
Safioleas K; Giamarellos-Bourboulis EJ; Carrer DP; Pistiki A; Sabracos L; Deliveliotis C; Chrisofos M
Cytokine; 2016 May; 81():28-34. PubMed ID: 26844659
[TBL] [Abstract][Full Text] [Related]
12. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis.
Astiz M; Saha D; Lustbader D; Lin R; Rackow E
J Lab Clin Med; 1996 Dec; 128(6):594-600. PubMed ID: 8960643
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
Kremer JP; Jarrar D; Steckholzer U; Ertel W
Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock.
Link A; Selejan S; Maack C; Lenz M; Böhm M
Crit Care; 2008; 12(6):R159. PubMed ID: 19091080
[TBL] [Abstract][Full Text] [Related]
15. Response of tumour necrosis factor-alpha to delayed in vitro monocyte stimulation in patients with septic shock is related to outcome.
Appoloni O; Vincent JL; Duchateau J
Clin Sci (Lond); 2002 Mar; 102(3):315-20. PubMed ID: 11869172
[TBL] [Abstract][Full Text] [Related]
16. Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock.
Melendez E; Whitney JE; Norton JS; Silverman M; Harju-Baker S; Mikacenic C; Wurfel MM; Liles WC
Int J Med Sci; 2019; 16(2):318-323. PubMed ID: 30745813
[No Abstract] [Full Text] [Related]
17. The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study.
Fang Y; Li C; Shao R; Yu H; Zhang Q
Thromb Res; 2018 Nov; 171():149-154. PubMed ID: 30312800
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis.
Bergmann M; Gornikiewicz A; Sautner T; Waldmann E; Weber T; Mittlböck M; Roth E; Függer R
Shock; 1999 Dec; 12(6):421-7. PubMed ID: 10588509
[TBL] [Abstract][Full Text] [Related]
19. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
20. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
